World Equity Group’s Labcorp LH Stock Holding History

World Equity Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,867	Closed	-$423K	–	375
2022 Q1	$423K	Buy	+1,867	New	+$439K	0.09%	226

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

World Equity Group's LH Position: Q2 2022 in Review

World Equity Group sold out of Labcorp (LH) in Q2 2022, closing a stake of 1,867 shares — an estimated $423K sold.

World Equity Group first reported a position in LH in Q1 2022 and held it in 1 quarter. The position peaked at $423K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

World Equity Group reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
World Equity Group sold 1,867 Labcorp shares in Q2 2022, an estimated $423K.
World Equity Group first reported a position in Labcorp in Q1 2022 and held it in 1 quarter.
World Equity Group's Labcorp position peaked at $423K in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on World Equity Group's 13F filing for Q2 2022, filed 6 Sep 2024.